Identification of Kinase Targets for Enhancing the Antitumor Activity of Eribulin in Triple-Negative Breast Cell Lines

Background: Triple-negative breast cancer (TNBC) is the most aggressive molecular subtype of breast cancer, and current treatments are only partially effective in disease control. More effective combination approaches are needed to improve the survival of TNBC patients. Eribulin mesylate, a non-taxa...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Xuemei, Lee, Jangsoon, Fuson, Jon A., Liu, Huey, Iwase, Toshiaki, Yun, Kyuson, Margain, Cori, Tripathy, Debu, Ueno, Naoto T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045293/
https://www.ncbi.nlm.nih.gov/pubmed/36979714
http://dx.doi.org/10.3390/biomedicines11030735

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045293/
https://www.ncbi.nlm.nih.gov/pubmed/36979714
http://dx.doi.org/10.3390/biomedicines11030735

Ejemplares similares